XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 160 filers reported holding XENON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,027,030 | -9.8% | 28,696 | -0.7% | 0.13% | -24.0% |
| Q4 2022 | $1,139,014 | +9.6% | 28,887 | +0.3% | 0.18% | -20.1% |
| Q3 2022 | $1,039,000 | -80.5% | 28,792 | -83.5% | 0.22% | -83.9% |
| Q2 2022 | $5,324,000 | -64.0% | 175,000 | -63.8% | 1.36% | -71.6% |
| Q1 2022 | $14,774,000 | -29.4% | 483,270 | -27.9% | 4.79% | -57.2% |
| Q4 2021 | $20,934,000 | – | 670,093 | – | 11.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |